Trial intelligence / Profile preview

PK Study of Naftin Cream 2% in Pediatric Tinea Corporis

NCT02466867Phase 4Completed

Sponsor
Merz
Start
Jan 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
3
01

Overview

A Phase 4 trial of naftifine organogel (MediQuest Therapeutics) in tinea corporis, sponsored by Merz. Started Jan 2014; status: completed.

02

Drugs

naftifine organogel (MediQuest Therapeutics)
03

Conditions

tinea corporis

Beyond the preview

Go deeper on NCT02466867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02466867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call